Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,43 € ↓ -0,01 (-0,01%)
2026-06-04
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionBlume Capital Management, Inc.
Latest Disclosed Ownership1,054 shares
Latest Disclosed Value $ 63,926
Blume Capital Management, Inc. ownership in BRM / Bristol-Myers Squibb Company

On May 1, 2026 - Blume Capital Management, Inc. filed a 13F-HR form disclosing ownership of 1,054 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $55,251 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 1,054 shares of Bristol-Myers Squibb Company. This represents a change in shares of 0.00% during the quarter. The current value of the position is $49,991 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-01 2026-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 1,054 0 0.00 64 12.50 0.0109
2026-02-05 2025-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 1,054 -450 -29.92 57 -16.42 0.0103
2025-11-06 2025-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 1,504 0 0.00 68 -2.90 0.0129
2025-07-30 2025-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 1,504 -503 -25.06 70 -43.44 0.0140
2025-05-06 2025-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 2,007 -197 -8.94 122 -1.61 0.0274
2025-02-10 2024-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 2,204 0 0.00 125 8.77 0.0279
2024-10-29 2024-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 2,204 -271 -10.95 114 11.76 0.0255
2024-08-05 2024-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 2,475 0 0.00 103 -23.88 0.0248
2024-05-02 2024-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 2,475 0 0.00 134 6.35 0.0324
2024-05-02 2023-12-31 13F/A-1 BRISTOL-MYERS SQUIBB COM 110122108 2,475 0 0.00 127 -11.89 0.0332
2024-02-07 2023-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 2,475 0 127 0.0332
2024-05-02 2023-09-30 13F/A-1 BRISTOL-MYERS SQUIBB COM 110122108 2,475 0 0.00 144 -9.49 0.0425
2023-11-03 2023-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 2,475 0 144 0.0425
2024-05-02 2023-06-30 13F/A-1 BRISTOL-MYERS SQUIBB COM 110122108 2,475 271 12.30 158 3.95 0.0463
2023-08-10 2023-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 2,475 271 158 0.0463
2024-05-02 2023-03-31 13F/A-1 Bristol-Myers COM 110122108 2,204 0 0.00 153 -3.80 0.0484
2023-05-08 2023-03-31 13F Bristol-Myers COM 110122108 2,204 0 153 0.0484
2023-02-08 2022-12-31 13F Bristol-Myers COM 110122108 2,204 -400 -15.36 159 -14.59 0.0536
2022-11-15 2022-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 2,604 0 0.00 185 -7.96 0.0697
2022-08-11 2022-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 2,604 -200 -7.13 201 -1.95 0.0794
2022-05-12 2022-03-31 13F Bristol-Myers COM 110122108 2,804 0 0.00 205 17.14 0.0676
2022-02-07 2021-12-31 13F Bristol-Myers COM 110122108 2,804 0 0.00 175 5.42 0.0578
2021-11-12 2021-09-30 13F Bristol-Myers COM 110122108 2,804 0 0.00 166 -11.23 0.0607
2021-08-10 2021-06-30 13F Bristol-Myers COM 110122108 2,804 0 0.00 187 5.65 0.0684
2021-05-10 2021-03-31 13F Bristol-Myers COM 110122108 2,804 0 0.00 177 1.72 0.0697
2021-02-09 2020-12-31 13F Bristol Myers COM 110122108 2,804 -200 -6.66 174 -3.87 0.0744
2020-11-12 2020-09-30 13F Bristol-Myers COM 110122108 3,004 0 0.00 181 2.26 0.0918
2020-08-06 2020-06-30 13F Bristol-Myers COM 110122108 3,004 0 0.00 177 5.99 0.0981
2020-05-07 2020-03-31 13F Bristol-Myers COM 110122108 3,004 0 0.00 167 -13.02 0.1070
2020-02-05 2019-12-31 13F Bristol-Myers COM 110122108 3,004 1,000 49.90 192 90.10 0.0939
2019-11-12 2019-09-30 13F Bristol-Myers COM 110122108 2,004 -351 -14.90 101 -5.61 0.0504
2019-07-29 2019-06-30 13F Bristol-Myers COM 110122108 2,355 0 0.00 107 -4.46 0.0542
2019-05-06 2019-03-31 13F Bristol-Myers COM 110122108 2,355 0 0.00 112 -8.20 0.0588
2019-02-05 2018-12-31 13F Bristol-Myers COM 110122108 2,355 250 11.88 122 -6.87 0.0697
2018-11-02 2018-09-30 13F Bristol-Myers COM 110122108 2,105 250 13.48 131 27.18 0.0684
2018-08-02 2018-06-30 13F Bristol-Myers COM 110122108 1,855 0 0.00 103 -11.97 0.0562
2018-05-04 2018-03-31 13F Bristol-Myers COM 110122108 1,855 -50 -2.62 117 0.00 0.0651
2018-02-09 2017-12-31 13F Bristol-Myers COM 110122108 1,905 -100 -4.99 117 -8.59 0.0599
2018-02-14 2017-09-30 13F/A-1 Bristol-Myers COM 110122108 2,005 0 0.00 128 14.29 0.0677
2017-11-13 2017-09-30 13F Bristol-Myers COM 110122108 2,005 0 128
2017-08-08 2017-06-30 13F Bristol-Myers COM 110122108 2,005 0 0.00 112 2.75 0.0636
2017-05-12 2017-03-31 13F Bristol-Myers COM 110122108 2,005 0 0.00 109 -6.84 0.0631
2017-01-30 2016-12-31 13F Bristol-Myers COM 110122108 2,005 -48 -2.34 117 5.41 0.0703
2016-11-07 2016-09-30 13F Bristol-Myers COM 110122108 2,053 48 2.39 111 -24.49 0.0680
2016-08-11 2016-06-30 13F/A-1 Bristol-Myers COM 110122108 2,005 -200 -9.07 147 4.26 0.0970
2016-08-04 2016-06-30 13F Bristol-Myers COM 110122108 2,005 147
2016-05-12 2016-03-31 13F Bristol-Myers COM 110122108 2,205 0 0.00 141 -7.24 0.0974
2016-05-26 2015-12-31 13F/A-1 Bristol-Myers COM 110122108 2,205 0 0.00 152 16.03 0.1075
2016-02-08 2015-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 2,205 152
2015-11-05 2015-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 2,205 0 0.00 131 -10.88 0.1063
2015-08-11 2015-06-30 13F BRISTOL MYERS SQUIBB COM 110122108 2,205 -100 -4.34 147 -1.34 0.1112
2015-05-05 2015-03-31 13F BRISTOL MYERS SQUIBB COM 110122108 2,305 -1,600 -40.97 149 -35.50 0.1033
2015-02-10 2014-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 3,905 1,800 85.51 231 113.89 0.1628
2014-11-12 2014-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 2,105 0 0.00 108 5.88 0.0840
2014-07-29 2014-06-30 13F BRISTOL MYERS SQUIBB COM 110122108 2,105 0 0.00 102 -6.42 0.0801
2014-05-13 2014-03-31 13F BRISTOL MYERS SQUIBB COM 110122108 2,105 -50 -2.32 109 -5.22 0.0865
2014-02-14 2013-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 2,155 2,155 115 0.0951
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.